Table 4.

Risk factors of more severe COVID-19 course – multivariate analysis

GROUP	OR	95% CI	p-value
Age per 10y	2.01	1.41, 2.91	<0.001
Male	1.46	0.71, 2.95	0.295
Pulmonary comorbidity	3.10	0.72, 10.56	0.092
BMI	1.07	1.00, 1.14	0.033
No current DMT	1.15	0.40, 3.10	0.787
Anti-CD20	7.04	3.10, 15.87	<0.001
High dose glucocorticoid therapy during the 2 months before COVID-19 onset	2.83	0.10, 7.48	0.041

n = 738, OR = odds ratio, CI = confidence interval, BMI = body mass index, DMT = disease modyfing drug, Anti-CD20 = ocrelizumab and rituximab